WGN’s “Plant Daddy” Tim Joyce is back to share some weekend gardening tips, including how to manage mosquitoes around your ...

Actress Evangeline Lilly shared her hospital experience after fainting on a beach, revealing injuries and a long history of unexplained blackouts.

The equal pay activist Lilly Ledbetter made headlines in 2007 when she sued her employer, Goodyear Tire and Rubber Company, for gender discrimination, resulting in a Supreme Court case and ...

Best Turmeric Gummies of 2025? Pilly Labs Delivers a Vegan, Clean-Label Gummy Supplement Designed for Everyday HealthChicago, May 07, 2025 (GLOBE NEWSWIRE) -- Turmeric has long been celebrated for ...

Eli Lilly And Co (NYSE:LLY) stock is 1.6% lower to trade at $870.31 at last check, after a rare double downgrade from HSBC to "reduce" from "buy," and a price-target cut to $700 from $1,150.

Clinically-Inspired Pilly Labs Collagen Gummies Combine Hydrolyzed Collagen, Vitamin C, and Biotin to Support Skin Elasticity, Joint Flexibility, and Hair Health.Chicago, April 26, 2025 (GLOBE ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Shop vibrant dresses, standout activewear, and iconic Lilly Pulitzer prints for 60% off—only for 48 hours. Grab your Lilly Pop-Up Sale favorites now before sizes and styles start selling out fast.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss. Latest U.S.

Eli Lilly stock surged as much as 17% after positive phase-three trial data came out for orforglipron. It found orforglipron, a GLP-1 weight-loss pill, led to significant weight and A1C reductions.

It's Thursday morning, 11:50 a.m. ET -- and Eli Lilly (LLY-2.40%) stock is off to the races!. This morning, the Indianapolis-based pharmaceutical giant announced that its new GLP-1 weight loss ...

Alzheimer’s patients won’t be able to order treatments, such as Lilly’s newly launched drug Kisunla, since they’re given as infusions in medical facilities. advertisement.